AM-101 in the Treatment of Post-Acute Tinnitus 2
NCT02040207
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
487
Enrollment
INDUSTRY
Sponsor class
Conditions
Tinnitus
Interventions
DRUG:
AM-101
Sponsor
Auris Medical AG